Forecast & Rating2 analysts currently cover BIOCYTOGEN-B, of which 2 give a positive rating. The average price target is HK$62.03, about 23.7% upside from the current price of HK$50.15. Coverage is limited, so the data is for reference only. Data as of Jul 6, 2026; this does not constitute investment advice.
Jul 4, 2026
Price forecast
HK$62.0323.69%
Forecast & RatingStrong buy
2analysts
Strong buy100.00%
Buy0.00%
Hold0.00%
Sell0.00%
Strong sell0.00%
Strong buy
2
Buy
0
Hold
0
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 26, 2026
Forecast met46.8%
Stock price$50.15
Average forecast price$62.0
Highest forecast price$62
Lowest forecast price$62
Average forecast price
$62.0
Highest forecast price
$62
Lowest forecast price
$62
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.